These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 14688061)

  • 1. Polyriboinosinic polyribocytidylic acid [poly(I:C)]/TLR3 signaling allows class I processing of exogenous protein and induction of HIV-specific CD8+ cytotoxic T lymphocytes.
    Fujimoto C; Nakagawa Y; Ohara K; Takahashi H
    Int Immunol; 2004 Jan; 16(1):55-63. PubMed ID: 14688061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of HIV-1 envelope (gp120)-specific cytotoxic T lymphocyte responses in mice by recombinant CHO cell-derived gp120 is enhanced by enzymatic removal of N-linked glycans.
    Doe B; Steimer KS; Walker CM
    Eur J Immunol; 1994 Oct; 24(10):2369-76. PubMed ID: 7523139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of HIV gp120-specific cytolytic T lymphocyte responses in vitro and in vivo using a detoxified pertussis toxin vector.
    Carbonetti NH; Tuskan RG; Lewis GK
    AIDS Res Hum Retroviruses; 2001 Jun; 17(9):819-27. PubMed ID: 11429123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells process exogenous viral proteins and virus-like particles for class I presentation to CD8+ cytotoxic T lymphocytes.
    Bachmann MF; Lutz MB; Layton GT; Harris SJ; Fehr T; Rescigno M; Ricciardi-Castagnoli P
    Eur J Immunol; 1996 Nov; 26(11):2595-600. PubMed ID: 8921944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic T lymphocyte precursor cells specific for the major histocompatibility complex class I-like antigen, Qa-2, require CD4+ T cells to become primed in vivo and to differentiate into effector cells in vitro.
    Muraoka S
    Eur J Immunol; 1991 Sep; 21(9):2095-103. PubMed ID: 1679712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR3-specific double-stranded RNA oligonucleotide adjuvants induce dendritic cell cross-presentation, CTL responses, and antiviral protection.
    Jelinek I; Leonard JN; Price GE; Brown KN; Meyer-Manlapat A; Goldsmith PK; Wang Y; Venzon D; Epstein SL; Segal DM
    J Immunol; 2011 Feb; 186(4):2422-9. PubMed ID: 21242525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced suppression of polyclonal CD8
    Mu C; Zhang X; Wang L; Xu A; Ahmed KA; Pang X; Chibbar R; Freywald A; Huang J; Zhu Y; Xiang J
    J Leukoc Biol; 2017 May; 101(5):1221-1231. PubMed ID: 28096300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Toll-like receptors in costimulating cytotoxic T cell responses.
    Schwarz K; Storni T; Manolova V; Didierlaurent A; Sirard JC; Röthlisberger P; Bachmann MF
    Eur J Immunol; 2003 Jun; 33(6):1465-70. PubMed ID: 12778463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary proliferative and cytotoxic T-cell responses to HIV induced in vitro by human dendritic cells.
    Macatonia SE; Patterson S; Knight SC
    Immunology; 1991 Nov; 74(3):399-406. PubMed ID: 1769689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycoprotein 96-activated dendritic cells induce a CD8-biased T cell response.
    Ramirez SR; Singh-Jasuja H; Warger T; Braedel-Ruoff S; Hilf N; Wiemann K; Rammensee HG; Schild H
    Cell Stress Chaperones; 2005; 10(3):221-9. PubMed ID: 16184767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
    Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
    J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for Toll-like receptor 4 in dendritic cell activation and cytolytic CD8+ T cell differentiation in response to a recombinant heat shock fusion protein.
    Palliser D; Huang Q; Hacohen N; Lamontagne SP; Guillen E; Young RA; Eisen HN
    J Immunol; 2004 Mar; 172(5):2885-93. PubMed ID: 14978090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triggering of TLR-3, -4, NOD2, and DC-SIGN reduces viral replication and increases T-cell activation capacity of HIV-infected human dendritic cells.
    Cardinaud S; Urrutia A; Rouers A; Coulon PG; Kervevan J; Richetta C; Bet A; Maze EA; Larsen M; Iglesias MC; Appay V; Graff-Dubois S; Moris A
    Eur J Immunol; 2017 May; 47(5):818-829. PubMed ID: 28266028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant.
    Hafner AM; Corthésy B; Merkle HP
    Adv Drug Deliv Rev; 2013 Oct; 65(10):1386-99. PubMed ID: 23751781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLR-independent induction of dendritic cell maturation and adaptive immunity by negative-strand RNA viruses.
    López CB; Moltedo B; Alexopoulou L; Bonifaz L; Flavell RA; Moran TM
    J Immunol; 2004 Dec; 173(11):6882-9. PubMed ID: 15557183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine.
    Fuller DH; Haynes JR
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1433-41. PubMed ID: 7888198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of primary human CD8+ T lymphocyte responses in vitro using dendritic cells.
    Zarling AL; Johnson JG; Hoffman RW; Lee DR
    J Immunol; 1999 May; 162(9):5197-204. PubMed ID: 10227993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.
    Wild J; Grusby MJ; Schirmbeck R; Reimann J
    J Immunol; 1999 Aug; 163(4):1880-7. PubMed ID: 10438922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo.
    Böhm W; Schirmbeck R; Elbe A; Melber K; Diminky D; Kraal G; van Rooijen N; Barenholz Y; Reimann J
    J Immunol; 1995 Oct; 155(7):3313-21. PubMed ID: 7561024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of rapid apoptosis for class I MHC molecule-restricted CD8(+) HIV-1 gp160-specific murine activated CTLs by free antigenic peptide in vivo.
    Nakagawa Y; Shimizu M; Norose Y; Takahashi M; Takahashi H
    Int Immunol; 2013 Jan; 25(1):11-24. PubMed ID: 22945875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.